Last reviewed · How we verify
NCT03522766
Evaluation of Urine Samples and Their Relation to Urinary Tract Infection
trial testing urine sample in Urinary Tract Infections in 30 participants. Completed in 23 September 2019.
23 September 2019
Quick facts
| Lead sponsor | Coloplast A/S |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 19 March 2018 |
| Primary completion | 23 September 2019 |
| Estimated completion | 23 September 2019 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- urine sample — full drug profile →
Conditions studied
- Urinary Tract Infections — all drugs for Urinary Tract Infections →
Sponsor
Coloplast A/S — full company profile →
Who can join
18 and older, any sex, with Urinary Tract Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim is to explore the human urine composition and its relation to urine tract infections
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03522766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of urine sample
Trials testing the same drug.
- NCT06820450 — Pilot Study to Characterize the Endometriosis Steroidome and Its Link to Endocrine Disruptors and Vaginal Dysbiosis · not yet recruiting
- NCT05323370 — Lymphangioleiomyomatosis, a Study on Cathepsin K · completed
- NCT05055856 — Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome · NA · completed
- NCT03698071 — Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis · NA · completed
- NCT03421184 — Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus · NA · completed
Other recruiting trials for Urinary Tract Infections
Currently open trials in the same condition.
- NCT06976125 — Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulat · NA · recruiting
- NCT06808451 — Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture · NA · recruiting
- NCT07186465 — Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis · Phase 4 · recruiting
- NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
- NCT06715306 — Intravenous Versus Oral Treatment of the Main Acute Infections · NA · recruiting
Other Coloplast A/S trials
Trials by the same sponsor.
- NCT07475468 — CP382 - Intermittent Catheter (IC) PRO Panel Plan · not yet recruiting
- NCT07384559 — Exploratory Study Investigating the Urinary Bladder During Intermittent Catheterization in Healthy and Spinal Cord Injur · NA · not yet recruiting
- NCT07376421 — Clinical Investigation Exploring a Newly Developed Ostomy Baseplate · NA · recruiting
- NCT07126327 — Peristeen Light Explorative Clinical Investigation · NA · recruiting
- NCT07316530 — Clinical Investigation Exploring a Newly Developed Ostomy Baseplate. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03522766 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Coloplast A/S
- Last refreshed: 5 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03522766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing